Rahul Aggarwal
@RahulAggarwalMD
Followers
1K
Following
2K
Statuses
484
Cardiology Fellow @HarvardMed @BrighamWomens | Learning about CV Outcomes & Health Services @SmithBIDMC & @DLBhattMD Group | Thankful for Friends & Family
Harvard Medical School
Joined October 2018
1/ Our NEW @CircAHA study, simultaneously published with #ESCCongress 🚨 We develop and validate the NEW #DOAC Score ➡️ A bleeding risk score for patients with #afib on DOACs ✅ We find our DOAC Score outperforms prior risk scores, including the HAS-BLED
6
64
207
0
0
4
RT @DLBHATTMD: Great presentation of REDUCE-IT CAD by @RahulAggarwalMD! @BrighamFellows @gabrielsteg @mmillermd1 #AHA24 #cardioX ht…
0
14
0
RT @rkwadhera: @AHAScience #AHA24 is just around the corner! Our research team will be presenting impactful and timely work focused on the…
0
10
0
RT @rkwadhera: The Health Policy & Equity Section @SmithBIDMC will be at #AHA24 @AHAScience! Check out this incredible group of trainees'…
0
12
0
RT @AdamRodmanMD: How should we feel about the incoming deluge of AI-generated text in our electronic health records? (if you don’t want…
0
37
0
RT @NigamMinali: Great to be at the @Cluster_buster meeting in Chicago with many @GrahamHeadache alum. Learned what's most important to #Cl…
0
4
0
Enjoyed presenting at #ESCCongress in London ✨SCORED - Sotagliflozin improves HF outcomes with increasing benefit for longer diabetes duration ✨REDUCE-IT sdLDL-C - icosapent ethyl improves CV outcomes irrespective of baseline small dense LDL ✨NHANES V1P - Enrollment criteria for ongoing trial Victorion-1 Prevent of inclisiran for primary prevention is likely generalizable to many high CV risk US patients. Incredibly greatful to my mentor @DLBHATTMD for the opportunities to learn about clinical trials and to my amazing co-authors for their expertise #ESCCongress2024 #Cardiology #ClinicalTrials
5
5
54
RT @HCPLiveNews: Hear from @RahulAggarwalMD as he discusses the results of a SCORED analysis examining effects of sotagliflozin according t…
0
3
0
RT @rkwadhera: Fantastic team dinner with the health policy research section @SmithBIDMC Very fortunate to work with incredibly talented m…
0
6
0
RT @rkwadhera: Terrific talk by Eden Engel-Rebitzer on work she's leading with our Health Policy Research Team @SmithBIDMC focused on how M…
0
2
0
Happy to share MDCalc is now hosting the DOAC Score Last year we published a calculator that predicts bleeding among AFib patients. It outperformed HAS-BLED in 4 multinational cohorts An international collaboration w/ @SmithBIDMC @TIMIStudyGroup @rwyeh
1/ Our NEW @CircAHA study, simultaneously published with #ESCCongress 🚨 We develop and validate the NEW #DOAC Score ➡️ A bleeding risk score for patients with #afib on DOACs ✅ We find our DOAC Score outperforms prior risk scores, including the HAS-BLED
5
35
116
Enjoyed collaborating with @GregoryPiazza4 and @bbikdeli on AAA attributed mortality, now published in @JACCJournals Addressing modifiable CV risk factors will be an important strategy to reduce AAA mortality @GregoryPiazza4 @bbikdeli
0
4
22
Excited to share our collaboration with the International Atherosclerosis Society and global experts leading to a consensus statement on elevated triglycerides We provide physicians a framework, backed by in-depth evidence. Special thanks to Dr. Libby
0
4
24
RT @rkwadhera: Terrific scientific discussion in @JAMA_current about the new @American_Heart PREVENT equations for cardiovascular risk asse…
0
16
0
RT @BrighamResearch: Did you know that 90% of people have cardiovascular-kidney-metabolic (CKD) syndrome? But what is it? Learn more about…
0
1
0
RT @BIDMC_Education: Excited to announce @AdamRodmanMD as our new Director of AI Programs at the Shapiro Institute! #AI #MedEd #Innovation…
0
5
0
RT @NEJMEvidence: In this Curbside Consult, cardiologists Rahul Aggarwal, MD, and @DLBhattMD address the common question “Which Test Should…
0
10
0